“Media reviews explain it to be a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional coverage.” Brunner has expressed stress regarding how some coverage of the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or analysis pep